3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
17
Lymphoma, B-Cell
17
Lymphoma, Large B-Cell, Diffuse
16
Lymphoma, Non-Hodgkin
12
Recurrence
11
Burkitt Lymphoma
10
Multiple Myeloma
7
Lymphoma
7
Neoplasms
6
Leukemia, Myeloid, Acute
6
Lymphoma, Mantle-Cell
5
Leukemia
5
Pancreatic Neoplasms
4
Lymphoma, Follicular
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Hematologic Neoplasms
4
Carcinoma, Hepatocellular
4
Neoplasm, Residual
3
Nasopharyngeal Carcinoma
3
Leukemia, B-Cell
3
Glioma
3
Colorectal Neoplasms
3
Breast Neoplasms
3
Stomach Neoplasms
2
Simpson-Golabi-Behmel syndrome
2
Sarcoma, Ewing
2
Rhabdomyosarcoma
2
Osteosarcoma
2
Melanoma
2
Lymphoma, B-Cell, Marginal Zone
2
Interventions
Gemcitabine
2
selinexor
1
ponatinib
1
neratinib
1
folfirinox
1
contrast agent BR1
1
cobimetinib
1
ceritinib
1
brigatinib
1
abemaciclib
1
Urination
1
S 1 (combination)
1
Radiotherapy
1
Radiosurgery
1
Practice Guidelines as Topic
1
Pancreaticoduodenectomy
1
Paclitaxel
1
Oxaliplatin
1
Long Interspersed Nucleotide Elements
1
Laparoscopy
1
Irinotecan
1
Immunotherapy, Adoptive
1
Floxuridine
1
Etoposide
1
Endosonography
1
Endoscopic Ultrasound-Guided Fine Needle Aspiration
1
Drug Therapy
1
Doxorubicin
1
Colchicine
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Carcinoma, Pancreatic Ductal
×
Immunotherapy, Adoptive
×
Clear all
NCT07153289
2025-09-03
ResCPa
University Hospital Tuebingen
Phase 1/2
Not yet recruiting
38 enrolled